300 related articles for article (PubMed ID: 3756930)
21. Common antigenic determinants on human melanoma, glioma, neuroblastoma, and sarcoma cells defined with monoclonal antibodies.
Seeger RC; Rosenblatt HM; Imai K; Ferrone S
Cancer Res; 1981 Jul; 41(7):2714-7. PubMed ID: 6166367
[TBL] [Abstract][Full Text] [Related]
22. Lactotetraose series ganglioside 3',6'-isoLD1 in tumors of central nervous and other systems in vitro and in vivo.
Wikstrand CJ; Longee DC; McLendon RE; Fuller GN; Friedman HS; Fredman P; Svennerholm L; Bigner DD
Cancer Res; 1993 Jan; 53(1):120-6. PubMed ID: 8416736
[TBL] [Abstract][Full Text] [Related]
23. Spatial distribution of tumor-specific monoclonal antibodies in human melanoma xenografts.
Shockley TR; Lin K; Nagy JA; Tompkins RG; Yarmush ML; Dvorak HF
Cancer Res; 1992 Jan; 52(2):367-76. PubMed ID: 1728408
[TBL] [Abstract][Full Text] [Related]
24. Antigenic heterogeneity of human brain tumors defined by monoclonal antibodies.
Stavrou D; Bise K; Groeneveld J; Stocker U; Kretzschmar HA; Keiditsch E; Mehraein P
Anticancer Res; 1989; 9(6):1489-96. PubMed ID: 2697177
[TBL] [Abstract][Full Text] [Related]
25. Highly selective recognition of human neuroblastoma cells by mouse monoclonal antibody to a cytoplasmic antigen.
Gross N; Beck D; Carrel S; Munoz M
Cancer Res; 1986 Jun; 46(6):2988-94. PubMed ID: 3516388
[TBL] [Abstract][Full Text] [Related]
26. Monoclonal antibody T-199 directed against human medulloblastoma: characterization of a new antigenic system expressed on neuroectodermal tumors and natural killer cells.
Feickert HJ; Pietsch T; Hadam MR; Mildenberger H; Riehm H
Cancer Res; 1989 Aug; 49(15):4338-43. PubMed ID: 2743322
[TBL] [Abstract][Full Text] [Related]
27. Monoclonal antibodies to human renal cell carcinoma: recognition of shared and restricted tissue antigens.
Vessella RL; Moon TD; Chiou RK; Nowak JA; Arfman EW; Palme DF; Peterson GA; Lange PH
Cancer Res; 1985 Dec; 45(12 Pt 1):6131-9. PubMed ID: 3904980
[TBL] [Abstract][Full Text] [Related]
28. 125I-labeled anti-epidermal growth factor receptor-vIII single-chain Fv exhibits specific and high-level targeting of glioma xenografts.
Kuan CT; Reist CJ; Foulon CF; Lorimer IA; Archer G; Pegram CN; Pastan I; Zalutsky MR; Bigner DD
Clin Cancer Res; 1999 Jun; 5(6):1539-49. PubMed ID: 10389943
[TBL] [Abstract][Full Text] [Related]
29. Surface antigenic characteristics of human glial brain tumor cells.
Wikstrand CJ; Mahaley MS; Bigner DD
Cancer Res; 1977 Dec; 37(12):4267-75. PubMed ID: 72598
[TBL] [Abstract][Full Text] [Related]
30. Expression of human fetal brain antigens by human tumors of neuroectodermal origin as defined by monoclonal antibodies.
Wikstrand CJ; Bigner DD
Cancer Res; 1982 Jan; 42(1):267-75. PubMed ID: 6274512
[TBL] [Abstract][Full Text] [Related]
31. Specific imaging of human brain tumor xenografts utilizing radiolabelled monoclonal antibodies (MAbs).
Bullard DE; Wikstrand CJ; Humphrey PA; Lee YS; Coleman RE; Zalutsky M; Bigner DD
Nuklearmedizin; 1986 Dec; 25(6):210-5. PubMed ID: 3808960
[TBL] [Abstract][Full Text] [Related]
32. Development of a xenograft glioma model in mouse brain.
Kaye AH; Morstyn G; Gardner I; Pyke K
Cancer Res; 1986 Mar; 46(3):1367-73. PubMed ID: 3943101
[TBL] [Abstract][Full Text] [Related]
33. [Reactivity of monoclonal antibodies ALT-01 and ALT-04 and identification of lung cancer-associated antigens].
Fan MZ; Qiu WR; Yu YB; Chen ZX; Cao SL; Wu RH; Wu H; Zhong JA; Ma YL; Xin YL
Zhonghua Zhong Liu Za Zhi; 1987 May; 9(3):161-4, 9. PubMed ID: 3447854
[TBL] [Abstract][Full Text] [Related]
34. Generation and characterization of B72.3 second generation monoclonal antibodies reactive with the tumor-associated glycoprotein 72 antigen.
Muraro R; Kuroki M; Wunderlich D; Poole DJ; Colcher D; Thor A; Greiner JW; Simpson JF; Molinolo A; Noguchi P
Cancer Res; 1988 Aug; 48(16):4588-96. PubMed ID: 3396010
[TBL] [Abstract][Full Text] [Related]
35. A new Mr 55,000 surface protein implicated in melanoma progression: association with a metastatic phenotype.
Boukerche H; Baril P; Tabone E; Bérard F; Sanhadji K; Balme B; Wolf F; Perrot H; Thomas L
Cancer Res; 2000 Oct; 60(20):5848-56. PubMed ID: 11059782
[TBL] [Abstract][Full Text] [Related]
36. Preclinical studies on the pharmacokinetic properties of human monoclonal antibodies to colorectal cancer and their use for detection of tumors.
McCabe RP; Peters LC; Haspel MV; Pomato N; Carrasquillo JA; Hanna MG
Cancer Res; 1988 Aug; 48(15):4348-53. PubMed ID: 3390831
[TBL] [Abstract][Full Text] [Related]
37. Monoclonal antibodies to human melanoma associated antigens: study of their specificity and visualization at the cellular level of the antigenic distribution.
Libert A; Ghanem G; Arnould R; Vercammen-Grandjean A; Carrel S; Lejeune F
Anticancer Res; 1983; 3(4):219-25. PubMed ID: 6576727
[TBL] [Abstract][Full Text] [Related]
38. Targeting human cancer xenografts with monoclonal antibodies labeled using radioiodinated, diethylenetriaminepentaacetic acid-appended peptides.
Stein R; Govindan SV; Mattes MJ; Shih LB; Griffiths GL; Hansen HJ; Goldenberg DM
Clin Cancer Res; 1999 Oct; 5(10 Suppl):3079s-3087s. PubMed ID: 10541347
[TBL] [Abstract][Full Text] [Related]
39. Murine monoclonal antibodies cytotoxic to human glioma cells in vitro.
Sánchez-Gómez MV; Conde-Guerri B; Sinués-Porta E; Matute C
Histol Histopathol; 1992 Oct; 7(4):619-24. PubMed ID: 1457984
[TBL] [Abstract][Full Text] [Related]
40. Treatment of human glioma and medulloblastoma tumor lines in athymic mice with diaziquone and diaziquone-based drug combinations.
Schold SC; Friedman HS; Bjornsson TD; Bigner DD
Cancer Res; 1984 Jun; 44(6):2352-7. PubMed ID: 6722774
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
